Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
Clinical trial NCT05857384 · COMPLETED
Trial details
- NCT number
- NCT05857384
- Sponsor
- Incannex Healthcare Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2024-07-31
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.